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STD-NMRTachyplesin-1, a disulﬁde stabilized β-hairpin antimicrobial peptide, can be found at the hemocytes of horse
shoe crab Tachypleus tridentatus. A cysteine deleted linear analog of tachyplesin-1 or CDT (KWFRVYRGIYRRR-
NH2) contains a broad spectrum of bactericidal activity with a reduced hemolytic property. The bactericidal
activity of CDT stems from selective interactions with the negatively charged lipids including LPS. In this
work, CDT–LPS interactions were investigated using NMR spectroscopy, optical spectroscopy and functional
assays. We found that CDT neutralized LPS and disrupted permeability barrier of the outer membrane. Zeta
potential and ITC studies demonstrated charge compensation and hydrophobic interactions of CDT with
the LPS-outer membrane, respectively. Secondary structure of the peptide was probed by CD and FT-IR exper-
iments indicating β-strands and/or β-turn conformations in the LPS micelle. An ensemble of structures, de-
termined in LPS micelle by NMR, revealed a β-hairpin like topology of the CDT peptide that was typiﬁed by
an extended cationic surface and a relatively shorter segment of hydrophobic region. Interestingly, at the
non-polar face, residue R11 was found to be in a close proximity to the indole ring of W2, suggesting a
cation–π type interactions. Further, saturation transfer difference (STD) NMR studies established intimate
contacts among the aromatic and cationic residues of CDT with the LPS micelle. Fluorescence and dynamic
light scattering experiments demonstrated that CDT imparted structural destabilization to the aggregated
states of LPS. Collectively, atomic resolution structure and interactions of CDT with the outer membrane-
LPS could be exploited for developing potent broad spectrum antimicrobial and anti-sepsis agents.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The emergence of drug-resistant bacteria has caused a major chal-
lenge to the human health care [1,2]. There are now a number of bac-
teria, termed as multi drug resistant strains or superbugs, with
protection against a number of conventional antibiotics [3–5]. Among
these superbugs, as comprehended, the Gram-negative ones e.g.
Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella
pneumoniae thought to be a major threat due to the deﬁciency of
the active drug candidates in the pipeline [5]. Therefore, novel anti-
biotics with different modes of actions are highly desirable to combat
infectious diseases. Cationic antimicrobial peptides (AMPs) are an, cysteine deleted analog of
magnetic resonance; Tr-NOE,
verhauser effect spectroscopy;
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rights reserved.integral component of the innate immune system. AMPs serve as
the ﬁrst line of defense with a broad spectrum of activity against
bacteria, viruses and fungi [6–9]. The evolutionary preserved AMPs
have been recognized as a promising lead for the development of
new antibiotics [6–9]. In humans, AMPs are involved for the probable
stimulation andmodulation of adaptive immunity [10,11]. As amode
of action, most of the AMPs disrupt the integrity of bacterial mem-
branes [12–14]. The amphipathic sequence features, typiﬁed by the
preponderance of cationic and hydrophobic amino acids, of AMPs
facilitate membrano-lytic activity toward microorganisms [12–14].
The disruption of cytosolic membrane by AMPs, causing cell lysis,
may occur following one or several mechanisms e.g. barrel stave, to-
roidal pore, carpeting sinking raft and lipid clustering [15–18]. Thus,
structural or SAR studies of AMPs are largely preformed with model
membranes consisted of negatively charged phospholipids plausibly
mimicking the plasma membrane of bacteria [15–18]. It may be
noted that while a variety of biophysical methods has been utilized
to understand interactions of AMPs with model lipid membranes,
the use of NMR techniques provided atomic-resolution insights in
terms of structure, membrane orientation and mechanisms [18,19].
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efﬁcient permeability barrier for antibiotics, AMPs and host defense
proteins [19–22]. A higher lethal concentration of AMPs is often
necessary to prevent growth of Gram-negative organisms as compared
to Gram-positive counterparts [23,24]. Some AMPs are known to be
quite ineffective against Gram-negative strains [23,24]. As observed,
in the context of LPS these AMPs undergo self-association preventing
their translocation through the outer membrane [24–26]. Therefore,
AMPs need to disrupt LPS mediated barrier of the outer membrane
in order to achieve the broad spectrum activity. Chemically, LPS consists
of three different segments, a distally located variable polysaccharide or
O-antigen domain, a relatively conserved hexa-acylated lipid A moiety
and an oligosaccharide domain covalently linking the lipid A and
O-antigen domains. Consequently, atomic-resolution structures and
interactions of AMPs in LPS lipids are vital to realize the mechanism of
action and for the further development of highly active peptide based
antibiotics [27–32]. Moreover, LPS, as termed endotoxin, is the causative
agent of fatal septic shock syndromes in human [33,34]. Thus, AMPswith
LPS binding and neutralizing ability may endow with scaffolds for the
generation of anti-endotoxic drugs [27,35,36].
Tachyplesin-1 or TP-1 (KWCFRVCYRGICYRRCR-NH2) is a well char-
acterized, structurally and mechanistically, AMP from the hemocyte of
horse shoe crab [37–39]. TP-1 has a broad spectrum of antimicrobial ac-
tivity against several strains of Gram-negative andGram-positive bacte-
ria, fungi and viruses [40,41]. The antimicrobial activity of TP-1 appears
to stem from the ability of the peptide to disorganize bacterial cell
membranes [37–39]. NMR studies demonstrated that TP-1 adopts β-
hairpin structure in solution and also in lipid micelles and bilayers
[38,42,43]. The antiparallel β-strands of β-hairpin structure of TP-1
are constrained by the disulﬁde bridges between residues Cys3–Cys15
and Cys7–Cys12 [37,38]. Replacement of disulﬁde bonds with various
amino acids has yielded important insight toward structure–activity re-
lationship for β-hairpin or β-sheet AMPs including TP-1 [44–47]. How-
ever, the consequences, in terms of activity and structures, of a
complete deletion of Cys residues from the amino acid sequences of
AMPs had been less frequently examined. In this regard, a shorter ana-
log of TP-1, 13-residue long, termed CDT, whereby all of the four Cys
residues were deleted from the primary structure of AMP, was investi-
gated for antibacterial activity, red blood cell lysis and liposome leakage
and vesicle binding [48]. CDT demonstrated a marked inhibition of
growth of Gram negative and Gram positive bacterial strains akin to
TP-1. The MIC (minimum inhibitory concentration) values of CDT
were even found to be lower against Escherichia coli and Listeria mono-
cytogenes in comparison to the native TP-1 peptide. In addition, CDT did
not cause any measurable hemolysis of erythrocytes at a concentration
as high as 200 μg/mL. Using a variety of biophysical methods including
solid state NMR studies, Ramamoorthy and coworkers demonstrated
selective interactions of CDT with the negatively charged lipid vesicles
e.g. POPE/POPG, POPC/POPG and POPC/LPS [48]. Based on the solid
state 31P NMR experiments with various lipid bilayers (POPC, POPC/
POPG), it was proposed that CDT may destabilize head group packing
of the lipid bilayers as a probable mode for bacterial cell lysis. However,
atomic resolution structures of CDT in any of these lipid environments,
in particularwith the LPS-outermembrane, are yet to be known. To gain
insights into the outer membrane permeabilization and endotoxin neu-
tralization, in this work, we have characterized atomic resolution struc-
ture and interactions of CDT in LPSmicelle by use of NMR spectroscopy,
ITC, dynamic light scattering and optical spectroscopy methods.
2. Materials and methods
2.1. Peptide, lipids and chemicals
LPS from E. coli 0111:B4, ﬂuorescein isothiocyanate (FITC) conju-
gated LPS from E. coli 055:B5 and 1-N-phenylnaph-thylamine (NPN)
were purchased from Sigma-Aldrich (St. Louis, MO). POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine) was obtained
from Avanti Polar Lipids™. CDT peptide was synthesized commercial-
ly by GL-Biochem (Shanghai, China) and was further puriﬁed by the
reverse-phase HPLC, Waters™, using a C18 column (300 Å pore size,
5 μm particle size) with a linear gradient of acetonitrile/water mix-
ture. The molecular weight of the peptide was conﬁrmed by mass
spectrometry.
2.2. Outer membrane permeabilization assay
Outer membrane permeabilization activity of CDT was analyzed
by 1-N-phenylnaph-thylamine (NPN) dye uptake. Mid-log phase E.
coli cells, obtained from an overnight culture, were centrifuged at
3000 g and resuspended in 10 mM sodium phosphate buffer to an op-
tical density of 0.6 at 600 nm. A stock solution of NPN previously pre-
pared in acetone was added to a ﬁnal concentration of 10 μM in
500 μL of E. coli cells and a basal ﬂuorescence was recorded. The
NPN dye was excited at 350 nm and the increase in ﬂuorescence in-
tensity (emission maximum) at 410 nm as a function of increasing
peptide concentrations (0.5–10 μM) was recorded. The maximal
value of NPN uptake was determined after the addition of 10 μL poly-
myxin B sulfate (0.64 mg/mL stock). The results were presented as
percentage membrane permeabilization relative to the membrane
permeabilization observed for polymyxin B.
2.3. TNF-α release assay
Murine macrophage (Raw 264.7) cells were revived to conﬂuency
in IMDM medium supplemented with FCS, glutamine and penicillin:
streptomycin in a 96 well micro-titer plate. A serial dilution of CDT
peptide from 1 μM to 10 μM was incubated with different concentra-
tions of LPS (1 ng/mL to 100 ng/mL) for 30 min. Peptide–LPS complex
was then added to conﬂuent macrophage cells and further incubated
for 6 h. The supernatant from each well was then analyzed by con-
ventional ELISA according to the manufacturer's instruction. The re-
lease of TNF-α was then detected spectrophotometrically at 540 nm.
2.4. Measurement of surface charge
Zeta potential studies for surface charge measurements were car-
ried out on a Zetasizer Nano ZS (Malvern Instruments, UK) equipped
with a 633 nm HeNe laser. E. coli cells were grown to mid-log phase
from overnight grown culture and suspended in 10 mM sodium phos-
phate buffer, pH 6.8 to a ﬁnal O.D. of 0.2. POPC:LPS (80:20 w/w) LUVs
were prepared by extrusion method. E. coli cells or LUVs were loaded
into a disposable zeta cell with gold electrode and the samples were
allowed to equilibrate for 3 min at 25 °C. Measurements were made
as a function of increasing concentration of CDT. A total of 5 measure-
ments of 100 runs each were carried out for all the concentrations of
peptide.
2.5. Fluorescence studies
All of the ﬂuorescence experiments were carried out in a Cary
Eclipse ﬂuorescence spectrophotometer (Varian, Inc., Australia)
equipped with a dual monochromator. Measurements were per-
formed using a 0.1 cm path length cuvette and a band width of
5 nm for excitation and emission. Intrinsic tryptophan ﬂuorescence
spectra of CDT were recorded by titrating 5 μM peptide with increas-
ing concentrations of E. coli 0111:B4 LPS. Fluorescence spectra were
recorded in 10 mM sodium phosphate buffer at pH 6.0. Fluorescence
quenching experiments for free and LPS micelle bound peptide
were recorded by stepwise addition of (0.02–0.2 M) acrylamide ei-
ther into the peptide or peptide–lipid solutions of 5 μM LPS. Quench-
ing of ﬂuorescence intensity at the emission maximum for the free
and LPS bound forms of CDT was noted and results were analyzed
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and F are the ﬂuorescence intensity at the emission maximum in the
absence and presence of quencher, respectively, KSV is the Stern–Vol-
mer quenching constant and [Q] is the molar concentration of acryl-
amide. The emission spectra, from 500 to 600 nm, of FITC
conjugated LPS, in 10 mM sodium phosphate buffer, pH 6.0, were
recorded with the excitation at 480 nm in samples containing
0.5 μM FITC-LPS.
2.6. Isothermal titration calorimetry (ITC) experiments
Binding afﬁnity of CDT with LPS and thermodynamic parameters
of interactions were determined using ITC experiments on a Nano-
ITC calorimeter (Micro Cal Inc, Northampton, MA). CDT and LPS
were separately dissolved in a 10 mM sodium phosphate buffer, pH
6.0. LPS samples were further vortexed for 10 min and sonicated for
5 min prior to use. Twenty injections, 0.4 μL each, from 550 μM
stock of CDT were made into a solution of 50 μM LPS, at an interval
of 4 min, with a stirring speed of 300 rpm and the heat exchange
was recorded at 20 °C. The heat of dilution of the peptide alone into
the buffer was subtracted from the titration data. The resulting data
were integrated with Micro Cal Origin 7.0. The data was ﬁtted with
models provided in the software and analyzed to determine the asso-
ciation constant Ka and the enthalpy change ΔH. The Gibb's free ener-
gy change ΔG and entropy change ΔS were calculated from the
fundamental thermodynamic equations: ΔG=−RT ln Ka and
TΔS=(ΔH−ΔG), respectively.
2.7. Dynamic light scattering (DLS) studies
Particle size distribution of LPS micelle in the presence and ab-
sence of CDT was determined using DLS measurements, performed
on a BI-200SM instrument equipped with a He–Ne laser and a BI-
900 AT auto-correlation system (Brookhaven Instruments Corp.,
Holtsville, NY). For DLS measurement, 1 μM LPS was dissolved in a
10 mM sodium phosphate buffer, pH 6.0 and was exposed to 90°
light scattering for 3 min. DLS measurements were recorded for LPS
in the presence of 2 μM CDT, under similar conditions. All samples
were ﬁltered, degassed and scanned using a 1-mm path length quartz
cuvette. Data were analyzed by the CONTINmethod supplied with the
instrument.
2.8. Circular dichroism (CD) and IR spectroscopy
Far-UV CD spectra of CDT were recorded using a Chirascan CD
spectrophotometer (Applied Photophysics Ltd., UK) with a 0.1 mm
path length of cuvette. CD data were collected with a spectral band-
width of 1 nm and a time constant of 1 s. Peptide concentration in
all experiments was ﬁxed to 100 μM. 50 μM LPS was used to record
secondary structural changes in the presence of lipid. Samples were
prepared in 10 mM sodium phosphate buffer at pH 6.0. FTIR spectra
were recorded on a Nicolet Nexus 560 spectrometer (Madison, USA)
purged with N2 and equipped with a MCT/A detector cooled with liq-
uid nitrogen. Attenuated total reﬂection (ATR) spectra were mea-
sured with a 25-reﬂection ATR accessory from Graseby Specac
(Kent, UK) and a wire grid polarizer (0.25 μM, Graseby Specac).
Approximately 200 μL of a D2O solution of LPS alone or in the pres-
ence of peptide in a 20:1 lipid/peptide molar ratio was applied onto
a trapezoidal (50 mm×2 mm×20 mm) Ge internal reﬂection ele-
ment (IRE). A dry, or D2O saturated, N2 stream ﬂowing through the
ATR compartment was used to remove bulk water (low hydration)
or to fully hydrate the sample (high hydration), respectively. A total
of 200 scans were collected at a resolution of 4 cm−1, averaged and
processed with one-point zero ﬁlling and Happ-Genzel apodization.
Percentages of secondary structure were estimated by ﬁtting
the amide I region (from 1700 to 1600 cm−1) after mild Fourierdeconvolution. The amide I band was Fourier self-deconvolved
(FSD) using a full-width at a half-height (FWHH) of 20 cm−1 and
an enhancement factor, k, of 2.0.
2.9. NMR experiments and structure determination
NMR experiments were performed on a Bruker DRX 600 MHz
spectrometer (Germany), equipped with a cryo-probe and pulse
ﬁeld gradients. NMR data processing and analysis were carried out
using the programs Topspin (Bruker) and SPARKY (Goddard, T. D.,
and Kneller, D. G., University of California, San Francisco), respective-
ly. A series of one dimensional 1H NMR spectra of CDT was obtained
by titrating aliquots of LPS, from a stock solution of 0.5 mM, in aque-
ous solution at pH 4.5 at 298 K. Two dimensional 1H–1H NOESY (mix-
ing time: 150 and 200 ms) and TOCSY (mixing time: 80 ms) spectra
of CDT, at 0.5 mM, in the presence of 10 μM LPS were acquired.
NOESY spectra of CDT in free solution were also obtained in an aque-
ous solution at pH 4.5 at 298 K. Saturation transfer difference (STD)
NMR experiments were carried out as described previously [49,50].
Typically, CDT (0.5 mM) was dissolved in 550 μL of D2O and pH was
adjusted to 4.5. Stock solution, 5 mg/mL, of LPS was prepared in
D2O solution at pH 4.5. All STD experiments were performed at
298 K in the presence of 10 μM LPS concentration using standard
STD pulse sequences and WATERGATE 3-9-19 sequence for water
suppression [49,50]. The on-resonance frequency of STD studies was
ﬁxed by acquiring a series of one-dimensional STD spectra at different
on-resonances in the range of 0 to −10 ppm with an interval of
0.5 ppm. Finally, an on-resonance frequency was set to −3.5 ppm
while the off-resonance frequency was ﬁxed to 40 ppm for STD ex-
periments. One dimensional STD NMR experiments were performed
with a scan number of 1024 for a typical spectral width of 12 ppm.
All STD spectra were multiplied by an exponential line broadening
function of 3 Hz, prior to Fourier transformation. Two-dimensional
STD-TOCSY spectra were recorded with 350 increments in t1 and 80
transients using a MLEV-17 spin lock ﬁeld of 80 ms. The relaxation
delay was set to 2.1 s. Saturation transfer was achieved by using 40
selective Gaussian 270 pulses with a duration of 50 ms.
LPS-bound structure of CDT was calculated based on NOE-driven
distance restraints. The upper bound of the inter proton distance
was determined from the volume of NOESY cross-peaks. The lower
bound of the inter proton distance was ﬁxed to 2.0 Å. It should be
noted that determination of the three-dimensional structure of the
peptide was largely driven by the medium and long-range NOEs, ex-
clusively present in the LPS bound state. The backbone dihedral angle
(Φ) was varied from−30 to−120° for non-glycine residues to limit
the conformational search. NMR structures of CDT were iteratively
calculated from an extended polypeptide chain in 7 cycles of simulat-
ed annealing using Cyana 2.1 [51] program. The 20 lowest-energy
structures without distance violations greater than 0.3 Å and no
angle violations greater than 5° were accepted into the ﬁnal ensem-
ble. Structures were visualized using MOLMOL and PyMOL software.
The quality of structures was determined using Procheck [52] and
the Protein Structure Validation Suite [53].
3. Results
3.1. Neutralization of LPS toxicity and disruption of the LPS-outer
membrane barrier by CDT
Owing to the interactions with the outer membrane of Gram-
negative bacteria, AMPs may confer neutralization of the toxicity of
LPS or endotoxin [19,27]. However, it may be noted that a number
of AMPs despite their interactions with LPS or outer membrane are
incapable of neutralizing endotoxin [27,54]. Typically, binding of
endotoxin neutralizing molecules with LPS would inhibit the activa-
tion of a cell surface receptor, TLR4, causing an inhibition of the
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[55]. The ability of CDT to neutralize endotoxin was examined by cy-
tokine, TNF-α, release assays from murine macrophage RAW cells. In
these experiments, macrophage cells were induced by three different
concentrations, 1 ng/mL, 10 ng/mL and 100 ng/mL, of LPS either in
the absence or in the presence of three different concentrations,
0.1 μM, 1 μM and 10 μM, of CDT peptide. As expected, CDT peptide
was able to inhibit, in a dose-dependent manner, LPS mediated
TNF-α secretion from macrophages (Fig. 1A). CDT, at a concentration
of 10 μM, had caused >80% neutralization of endotoxin even for the
highest concentration of LPS (100 ng/mL) (Fig. 1A). In addition, a sig-
niﬁcant inhibition of TNF-α production was seen for the lower doses,
0.1 μM and 1 μM, of CDT for LPS concentrations of 1 ng/mL and 10 ng/
mL (Fig. 1A). There was >70% neutralization of endotoxin by CDT, at
concentrations of 0.1 μM and 1 μM, against 1 ng/mL and 10 mg/mL
LPS, respectively (Fig. 1A).
In order to exert lethal effect against Gram-negative pathogens,
potent AMPs should disrupt the integrity of the outer-membrane. 1-
N-phenylnaphthylamine (NPN) is a ﬂuorescent hydrophobic dye
which shows a low intensity of ﬂuorescence emission in aqueous so-
lution. NPN is excluded by the outer-membrane; however, a loss inFig. 1. LPS neutralization and outer membrane permeabilization by CDT. (panel A) Bar
diagram showing inhibition of TNF-α secretion from macrophage stimulated with LPS
in the presence of CDT peptide. Experiments were carried out with three different con-
centrations of LPS and three different concentrations of CDT. The percentage inhibition
of TNF-α release by CDT was normalized with macrophage stimulated without peptide.
As seen, CDT efﬁciently reduces TNF-α release by inhibiting LPS binding to macrophage
cells. (panel B) Plot showing permeabilization of outer membrane of E. coli cells to the
hydrophobic dye NPN as a function of concentration of CDT peptide. NPN showed an
enhancement in ﬂuorescence emission intensity and a blue shift in emission maxima
(inset panel B) upon addition of CDT. The % membrane permeabilization was estimated
with reference to polymyxin B.the integrity of outer-membrane facilitates incorporation of NPN to
the cell membranes yielding an enhanced ﬂuorescence intensity of
the probe.
We measured NPN ﬂuorescence emission in solutions containing
E. coli cells either in the absence or in the presence of different con-
centrations of CDT peptide. The emission intensity of NPN, in E. coli
cell solutions, was also determined for 10 μM polymyxin B as a posi-
tive control. The relative emission intensity of NPN measured at dif-
ferent concentrations of CDT was expressed with respect to that of
polymyxin B (Fig. 1B). Fig. 1B shows the relative ﬂuorescence increase
of NPN as a function of concentrations of CDT peptide. As evident,
additions of CDT peptide caused a dramatic increase in the relative
ﬂuorescence intensity of NPN, indicating a permeabilization of the
LPS-outer membrane. There was also a progressive blue shift in the
emission maxima of NPN with increase in concentrations of CDT
(Fig. 1B, inset). Thus, in the presence of CDT, NPN was able to insert
into the hydrophobic environment of membranes of E. coli cells yield-
ing increased ﬂuorescence intensity and a blue shift for the emission
maximum. In other words, CDT induced an efﬁcient permeabilization
of the outer-membrane of E. coli cells (Fig. 1B). The entry of NPN into
the bacterial cell membranes was considered as a signature of the
permeabilization of the outer membrane mediated by the cationic
AMPs, as termed ‘self-promoted’ uptake process [56]. Taken together,
cytokine release and NPN ﬂuorescence experiments demonstrated
that CDT efﬁciently neutralizes toxicity of LPS and also disrupts integ-
rity of the outer-membrane.
3.2. Surface charge neutralization of E. coli cells by CDT
Zeta potential was measured for E. coli cells and LUV composed of
POPC and LPS at various concentrations of CDT (Fig. 2). A negative
zeta potential ~−20 mV was observed for the solutions of E. coli
cells (Fig. 2). The LPS-outer membrane of E. coli is known to be con-
tributing for the negative zeta potential [57,58]. Additions of CDT
peptide caused a dramatic increase in zeta potential of E. coli cells
(Fig. 2). Zeta potential was changed from −20 mV to 0 mV only at
the 2 μM concentration of peptide (Fig. 2A). At the higher peptide
concentrations (>2 μM) positive values of zeta potential were
detected (Fig. 2). An analogous observation was also made for the
zeta potential for mixed lipid vesicles containing zwitterionic lipid
POPC and negatively charged LPS (Fig. 2). The neutralization of the
surface charge (0 mV zeta potential) of the LPS-outer membrane by
CDT can largely be accounted for a balance in electrostaticFig. 2. Effect of CDT to the surface charge of E. coli and LUV: plot showing changes in
zeta potential of E. coli cells and LUV of POPC-LPS (80:20 w/w) upon additions of
CDT peptide. The dotted line at 0 mV zeta potential indicates an electrically neutral sur-
face of E. coli and LUV obtained at 2 μM and 1 μM peptide concentrations, respectively.
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charged LPS lipids. However, the positive zeta potential, observed at
>2 μM concentration of CDT, of E. coli cells may be interpreted as in-
sertion of the peptide into the hydrophobic milieu of the LPS-outer
membrane membranes [57,58]. These data demonstrated that as a
mode of action CDT efﬁciently neutralizes surface charges of the
outer membrane of E. coli cells and inserts into the hydrophobic envi-
ronment of lipids.
3.3. Localization of Trp residue of CDT in LPS micelle
CDT contains a single Trp residue at position 2 in the amino acid
sequence. The interactions between CDT and LPS were probed by
means of intrinsic Trp emission and quenching experiments. In the
free solutions, Trp residue of CDT showed an emission maximum at
~355 nm, indicating that Trp is highly solvent exposed (Fig. 3A). In-
clusion of LPS at various concentrations into solutions containing
CDT yielded a marked enhancement in the ﬂuorescence emission in-
tensity of Trp residue along with a blue shift in the emission maxi-
mum (Fig. 3A). At a 10 μM of LPS concentration, Trp residue of the
peptide had an emission maximum of ~345 nm (Fig. 3A). These ob-
servations delineated the incorporation of Trp residue of CDT into
the hydrophobic environment of LPS micelles. The extent of solvent
accessibility of Trp was further determined by ﬂuorescence quench-
ing using acrylamide as a quencher. There was a limited quenching
of Trp of CDT in complex with LPS in comparison to the free peptideFig. 3. Trp ﬂuorescence emission and quenching of CDT. (panel A) Fluorescence emis-
sion spectra of Trp residue of CDT at different concentrations of LPS. (panel B) Plot
showing a comparison of quenching of Trp ﬂuorescence by acrylamide. Trp experi-
enced both a blue shift in emission maxima (panel A) and a limited acrylamide
quenching in the presence of LPS (panel B).(Fig. 3B). The Stern–Volmer quenching plots estimated a quenching
constant (Ksv) of 20.0 and 8.4 for free and LPS-bound CDT, respective-
ly (Fig. 3B). Collectively, ﬂuorescence studies established that Trp res-
idue of CDT is inserted into the non-polar milieu of the LPS lipid
micelles with a restricted exposure to the aqueous solvent.3.4. Secondary structures of CDT in LPS micelle
The global secondary structures of CDT were examined by CD and
IR spectroscopic methods. Fig. 4A shows far UV CD spectra of CDT in
free solution and in the presence of 50 μM LPS. The far UV CD spectra
of CDT in buffer solutions were characterized by an intense single
negative band at 200 nm, indicating random conformations of the
peptide (Fig. 4A). By contrast, the far UV CD spectra of CDT obtained
in a solution containing LPS micelles were dominated by the presence
of two bands, with negative ellipticity, at 215 nm and 202 nm, imply-
ing structural transitions (Fig. 4A). The CD band detected at the wave-
length at 215 nm could be interpreted in terms of populated β-sheet
like structures of CDT in LPS micelles. Note that the estimation of sec-
ondary structures from CD spectra appeared to be complicated by the
potential contribution to the far UV CD bands from the number of ar-
omatic residues in CDT. A more deﬁnitive assignment of secondary
structures of CDT in LPS micelles was further obtained from FT-IR
studies. The secondary structure of CDT was determined following
previous assignments in the amide I [59]. The spectra in the amide I
region of CDT is shown after the subtraction of the LPS contributionFig. 4. Secondary structure of CDT in LPS by CD and IR spectroscopy: (panel A) far-UV
CD spectra of CDT in the absence (solid line) and presence (dashed line) of 50 μM LPS.
(panel B) Amide I and II regions corresponding to peptide CDT mixed with LPS in the
presence of H2O (red) and D2O (blue). The wavenumbers (in cm−1) of the main
bands of both spectra are indicated.
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spectrum in H2O were centered at 1668 and 1635 cm−1. The former
band is indicative of β-turns or β-structures [59], whereas the band
at 1635 cm−1 originates solely from β-structures. In any case, none
of these bands can be assigned to α-helical structures or to random
coils. The amide II band is visible at 1542 cm−1, whereas the band
at 1517 cm−1 corresponds to the tyrosine side chain of the peptide.
After D2O exchange (blue spectrum), the amide II appears to be
completely shifted to lower wave numbers, which indicates a com-
plete exchange (Fig. 4B). In the amide I, there was a small shift,
from 1668 to 1671 cm−1, and from 1635 to 1632 cm−1. Due to the
uncertainty in the assignment of the high frequency band, it is difﬁ-
cult to estimate the secondary structure composition, but one can
refer to two limit situations; if the assignment of the 1668 cm−1
band corresponds to β-structure, then the peptide has 100% β-
structure in LPS. If this band is assigned to β-turns, these would rep-
resent 58±8% of the peptide, whereas 42±12% is β-structure. These
results apply regardless of the level of hydration: in the IR spectrum
obtained in H2O, bulk water was removed by nitrogen, whereas the
sample in D2O was hydrated in the ATR conditions. Yet, in these
two conditions the amide I spectra appeared similar, except for
small shifts due to H/D exchange.
3.5. Interactions of CDT and LPS by ITC
The binding afﬁnity and thermodynamic parameters of interac-
tions of CDT with LPS were quantiﬁed by use of ITC measurements.
Fig. 5 shows a representative thermogram (at top) and integrated
heats of binding between CDT and LPS (bottom) at 25 °C. As can be
seen, LPS-peptide complex formation is driven by an endothermic re-
action as indicated by an upward trend of the ITC peaks and a positive
integrated heat (Fig. 5). An endothermic binding signiﬁes a predomi-
nant role of hydrophobic interactions in the LPS–peptide complexFig. 5. Interactions between LPS and CDT by ITC. ITC measurement of 550 μM CDT ti-
trated into 50 μM E. coli LPS in 10 mM sodium phosphate, pH 6.0 is shown at 298 K.
The upper panel shows the ITC peaks plotted as power (μcal s−1) against time (min).
The lower panel shows the resulting integrated heats of the binding. ITC parameters
are listed in Table 1.formation. Note that interactions between AMPs and LPS have been
found to be endothermic in nature at 25 °C or at lower temperatures,
however, at higher temperatures (≥40 °C) exothermic binding to LPS
was observed for some peptides [29,60,61]. This behavior has been
rationalized in terms of phase transitions, gel phase (at 20 °C) to liq-
uid crystalline phase (40 °C), of LPS lipids [60]. The equilibrium asso-
ciation constant (Ka) of interactions between CDT and LPS has been
estimated to be 8.23 μM−1 (Table 1). All other thermodynamic pa-
rameters, ΔG, ΔH and TΔS, are listed in Table 1. The favorable change
of free energy (ΔG) of interactions has been largely accounted by the
positive change of entropy TΔS, as evident from the endothermic
driven binding process (Table 1).
3.6. NMR characterization of CDT in LPS micelles
Sequence-speciﬁc resonance assignment of CDT in free solution
was made using two-dimensional 1H–1H TOCSY and NOESY spectra
(Supplementary Fig. S1) [62]. In the free-state, the NOESY spectra of
CDT were predominantly characterized by the sequential and intra-
residue NOEs, indicating random conformations (Supplementary
Fig. S2). Additions of low concentrations of LPS into solution contain-
ing CDT had resulted in broadening of NMR resonances, indicating a
fast exchange between free and LPS-bound states of the peptide at
NMR time scale (data not shown). Under such fast exchange regime,
peptides may generate NOEs corresponding to the LPS-bound states
that are detected in the NOESY spectra, also termed tr-NOESY
[63,64], correlating resonances of the free peptides. tr-NOESY experi-
ment is typically utilized to determine conformations of ligands, with
a dissociation constant (Kd) of the mM–μM range, while bound to a
high-molecular weight receptor [63,64]. It may be noted that LPS
forms high molecular weight micelles at a signiﬁcantly low concen-
tration, 1 to 2 μM, than any other lipids [65], permitting observation
of tr-NOEs from LPS-bound peptides [19,27–30]. As such, tr-NOESY
has been the only method for the determination of atomic resolution
structures of AMPs and LPS binding peptides in LPS micelle [27–30].
tr-NEOSY spectra of CDT obtained in the presence of 10 μM of LPS
(see Materials and methods) revealed a large number of NOE contacts
among the backbone–backbone, backbone–sidechain and sidechain–
sidechain proton resonances. Fig. 6A shows a section of the tr-
NOESY spectrum correlating NOEs among downﬁeld shifted amide
and aromatic proton resonances (7.5–8.5 ppm) with the upﬁeld
shifted aliphatic proton resonances (0.9–4.6 ppm). Further, the indole
sidechain (NεH) proton of residue W2, at 10.1 ppm, delineated sever-
al NOEs with the aliphatic sidechain protons (Fig. 6B). By contrast,
there was a lack of NOEs for indole sidechain (NεH) proton for the
free peptide (Fig. 6 C). Analyses of tr-NEOSY spectra demonstrated
preponderance of sequential, medium-range and long-range NOE
contact for CDT in LPS micelle (Supplementary Fig. S3 and Table S1).
Noticeably, there were a number of long-range NOEs among residues
W2/I9, W2/R11, F3/R13, V5/R11, V5/R12 and R4/R14 of CDT in LPS
micelle (Table S1). Fig. 7 summarizes the type and number of NOEs
observed for CDT in LPS micelle. As can be seen, the residues W2,
F3, R4 and V5 at the N-terminus and residues I9, R11, R12 and R13
at the C-terminus of CDT are involved in long-range NOE interactions
in the presence of LPS micelles (Fig. 7). By contrast, residues, Y6−G8,
at the middle of the sequence were primarily characterized by the
short-range NOEs (Fig. 7).
3.7. Three-dimensional structure of CDT in LPS micelle
An ensemble of structures of CDT, in complex with LPS micelles,
was derived based on 139 NOE driven distance constraints including
19 medium-range and 25 long-range NOEs (Table 2). Fig. 8A shows
a superposition of all backbone atoms (Cα, N, and C′) of the twenty
lowest energy structures of CDT in LPS micelle. The RMSD values for
backbone and heavy atoms from the mean structure were estimated
Fig. 6. 2D 1H–1H tr-NOESY spectra of CDT in LPS micelles. (panel A) A selected section of 1H–1H 2D tr-NOESY spectrum of CDT obtained in the presence of LPS micelles showing NOE
correlations from downﬁeld shifted aromatic and amide proton resonances (ω2 dimension) with upﬁeld shifted aliphatic proton resonances (ω1 dimension). A comparison of NOE
connectivities correlating the most downﬁeld shifted NεH proton resonance ~10.1 ppm of residue Trp2 with aliphatic proton resonances of CDT in LPS micelles (panel B) and in free
solution (panel C).
1619R. Saravanan et al. / Biochimica et Biophysica Acta 1818 (2012) 1613–1624to be 0.08±0.04 Å and 1.58±0.26 Å, respectively (Table 2). The LPS-
bound structure of CDT is characterized by a type II′ β-turn for the
amino acid residues Y6 (i)–R7(i+1)–G8(i+2)–I9(i+3) (Fig. 8B).
The stereochemistry of the type II′ β-turn is maintained by a positive
backbone ϕ dihedral angle for residue G8 located at the i+2 position
in the turn (Fig. 8B). In addition, the carboxyl oxygen (C_O) atom of
residue Y6 has been found to be in close proximity with the amide hy-
drogen (NH) atom of residue I9, indicating the existence of a potential
hydrogen bonding at the β-turn region. The residues W2–V5 and
Y10–R13 at the N- and C-termini, respectively, assume extended or
β-strand conformations. The two β-strands of CDT maintain an anti-
parallel orientation through packing interactions among sidechains
of aromatic and aliphatic amino acid residues (Fig. 8B and C). Notably,
the indole ring of residue W2 shows van der Waals' packing interac-
tions with the non-polar residues V5 and I9 (Fig. 8B). Further, the
sidechain of residue W2 is also in a close proximity with the cationic
sidechain of residue R11, plausibly indicating the involvement of
cation–π interactions (Fig. 8B and C). The overall structure of CDT in
LPS micelles resembles a β-hairpin topology. The β-hairpin structure
of CDT deduced in LPS micelles is largely amphipathic with an aro-
matic and non-polar surface comprised by residues W2, F3, V5, Y6
and I9 and a positively charged surface made of cationic residues
R4, R7, R12 and R13 (Fig. 8C and D). At the cationic surface of CDT,
the guanidinium sidechain of residue R7, from the β-turn, andTable 1
Binding parameters obtained for CDT–LPS interactions in 10 mM sodium phosphate
buffer with pH 6 at 20 °C by ITC experiments.
Ka Kd ΔH ΔG TΔS
(μM) (μM−1) (kcal/mol) (kcal/mol) (kcal/mol)
8.23±1.32 0.12±0.4 8.9±0.24 −6.0 14.9guanidinium sidechains of residues R12 and R13, from the C-
terminal strand, are found to be separated with an average distance
of 14 Å–15 Å (Fig. 8E). Note that such a distance is geometrically sim-
ilar to the inter-phosphate distance of the lipid A moiety of LPS [19].
This observation may indicate that preferential ionic interactions
may occur between the positively charged sidechains of residues R7,
R12 and R13 with the phosphate groups of di-glucosamine of lipid
A domain of LPS.Fig. 7. Distribution of NOEs of CDT in LPS micelles: bar diagram summarizing NOE con-
tacts detected for each amino acid residue of CDT in the complex with LPS micelles. As
can be seen residue Trp2 yielded as many as 45 NOE interactions including a number of
long-range NOEs.
Fig. 8. Description of the 3-D structure of CDT in LPS micelles: (panel A) superposition of backbone atoms (N, Cα, C′) of the twenty lowest energy structures (in stereo) of CDT bound
to LPS, obtained from CYANA 2.1. (panel B) A representative structure of CDT in LPS micelles showing β-hairpin like topology and sidechain orientation. (panel C) The β-hairpin like
structure of CDT showing amphipathic segregation of amino acid residues. (panel D) Electrostatic surface potential of CDT structure in LPS micelles in two different orientations.
(panel E) The polar or cationic face of the β-hairpin structure of CDT delineating a distance of ~15 Å between the nitrogen atoms of the sidechain guanidinium group of residues
R13 and R7. This distance would be geometrically compatible with the inter-phosphate distance of the lipid A moiety of LPS.
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difference (STD) NMR
STD-NMR has been utilized to elucidate residues of AMPs in close
proximity with LPS micelle [27,28,49,50]. The one-dimensional STD
spectra of CDT demonstrated strong STD effects particularly for the aro-
matic and aliphatic sidechain proton resonances of CDT with LPS mi-
celles, indicating an intimate association of the entire peptide with
LPS micelle (Supplementary Fig. S4). By use of 2-D STD-TOSCY,
residue-resolved interactions of CDT with LPS micelles were further
achieved. Fig. 9 shows selected sections of the STD-TOCSY spectra
showing correlations among the aliphatic proton resonances (panelTable 2
Summary of structural statistics of the twenty lowest energy structures of CDT bound
to LPS micelles.
Distance restraints
Intra-residue (|i− j|=0) 39
Sequential (|i− j|=1) 56
Medium range (2≤ |i− j|≤4) 19
Long-range (|i− j| 5) 25
Total NOE constraints 139
Dihedral angle constraints (Φ) 12
Constraints violations
Min NOE violation (Å) 0.09
Max NOE violation (Å) 0.26
Deviation from mean structure
Backbone atoms (N, Cα, C′) (Å) 0.08±0.04
Heavy atoms (Å) 1.58±0.26
Ramachandran plot analysis
% residues in the most favorable region 75.5
% residues additionally allowed region 24.5
% residues in the generously allowed region 0
% residues in the disallowed region 0A) and that of for the downﬁeld shifted aromatic ring proton resonances
(panel B). The STD-TOCSY spectra were interpreted based on the previ-
ous studieswhereby resonances delineating cross-peaks are considered
to be arising from the close contact of those residues with LPS micelle
[29,50]. In the STD-TOCSY spectra, CαH proton resonances of residues
V5 and I9 showed correlationswith the respective sidechain resonances
(Fig. 9A). In addition, intense STD-TOCSY cross-peaks can be seen
among the sidechain resonances of the residues V5 and I9 (Fig. 9A).
These observations indicated that the backbone and the sidechain pro-
tons of V5 and I9 of CDT are in close proximity with the LPS micelles. By
contrast, none of the aromatic residues, W2, F3, Y7 and Y10, of CDT
exhibited cross-peaks between the CαH and CβH resonances in the
STD-TOCSY spectra, indicating their limited contact with the LPS mi-
celle. The backbone CαHs of arginine residues, R4, R7, R11 and R13, ei-
ther showed no cross-peaks or weaker cross-peaks with the sidechain
CβHs, CγHs and CδHs proton resonances, implying restricted contacts
with the LPSmolecules (Fig. 9A). However, the sidechainmoieties of ar-
omatic and cationic arginine residues of CDT demarcated a close prox-
imity with the LPS micelle. There were strong cross-peaks observed in
the STD-TOCSY spectra correlating ring proton resonances of aromatic
residues W2, F3 and Y6/Y10 of CDT (Fig. 9B). Furthermore, the side-
chain resonances of the arginine residues exhibited strong cross-
peaks, clearly seen between the CδHs resonating around 3.0 ppm to
3.2 ppm with the CβHs and CγHs (Fig. 9A). Taken together, STD-
TOCSY studies demonstrated that CDT has been effectively inserted
within the LPS micelle predominantly employing sidechains of aromat-
ic, aliphatic and cationic residues. However, the backbone region of the
structure, except for V5 and I9, appears to contain only limited insertion
within the LPS micelle.3.9. Perturbation of LPS micelles by CDT peptide
Interactions of AMPs with LPS have been observed to cause disor-
ganization of the micelle structure of LPS [66,67]. We utilized FITC
Fig. 9. Localization of CDT in LPS micelles by STD NMR: (panel A) STD-TOCSY spectrum of CDT presence of LPS showing correlations among aliphatic proton resonances. Through
bond connectivities detected in STD-TOCSY spectra for amino acid residues of CDT are shown by broken lines. (panel B) STD-TOCSY spectrum of CDT presence in LPS showing cor-
relations among aromatic proton resonances. STD-TOCSY spectra were acquired in D2O using a spin-lock MLEV17 sequence with a mixing time of 80 ms.
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tering (DLS) experiments probing plausible changes of LPS upon bind-
ing to CDT peptide. The intensity of FITC ﬂuorescence emission of
FITC-LPS is largely quenched due to the self association of LPS mole-
cules. Additions of CDT peptide into solution containing FITC-LPS had
produced a signiﬁcant enhancement of the emission intensity of FITC
ﬂuorescence (Fig. 10A). The dequenching of FITC ﬂuorescence of FITC-
LPS demonstrated that binding of CDT to LPSmicelles induces a dissoci-
ation of LPS aggregates. The dissociation of LPSmicelles into smaller size
aggregates can also be seen fromDLS studies. In the absence of CDTpep-
tide, LPS showed particle sizes with diameter centered at 5000 nm
(Fig. 10B). There was a large shift in the distribution of LPS aggregate
sizes in the presence of CDT peptide, whereby populations of LPS aggre-
gates having smaller sizes, with diameter of 500 nm, became apparent
upon addition of CDT peptide (Fig. 10C). Thus, FITC ﬂuorescence and
DLS data established that CDT peptide is able to impart perturbation
of structural organizations of LPS micelles.
4. Discussion
The disulﬁde bonded β-hairpin structures of AMPs like TP-1, prote-
grins and polyphemusin exhibited a high correlation with anti-
pathogenic activity [42–44,68,69]. In particular, linear analogs of TP-
1 either with reduced disulﬁde bonds or Cys mutated to Ala showed
lack of β-hairpin structure and markedly attenuated anti-bacterialactivity [40–42,44]. In this regard, NMR techniques, both solution
and solid, have been vital in determining atomic resolution structures,
localization and structure–activity correlations of AMPs in a variety of
model lipid membranes [15,18,19]. It may be interesting that the CDT
peptide, despite the absence of disulﬁde bridges or complementary ar-
omatic packing interactions, has retained β-hairpin like structure in
complex with LPS micelle (Fig. 8). The β-hairpin structure of TP-I
(KWCFR5VCYRG10ICYRR15CR-NH2) is well characterized by a β-turn
for the centrally located residues Y–R–G–I [36,40]. As seen, the β-
turn is even now preserved for these residues, Y6–R–G–I9, in the
LPS-bound structure of CDT (Fig. 8B). The β-hairpin topology of CDT,
stabilized in LPS micelles, is sustained by the unique packing interac-
tions between the aromatic ring of W2 and the sidechain of non-
polar amino acids of V5 and the cationic sidechain of residue R11
(Fig. 8B). There is also a close proximity between residues W2 and
I9, supported by the NOEs involving indole ring protons of W2 with
sidechain protons of I9 (Table S1). These packing interactions have
rendered an approximate anti-parallel orientation of the hairpin
structure of CDT in LPS. The ‘ﬂipping’ of the bulky indole ring ofW2 to-
ward the residues of the β-turn has created a twist for the anti-parallel
strands (Fig. 8B). On the other hand, the β-hairpin structure of TP-1
has been found to be rigid as a result of disulﬁde bridges and inter-
strand packing interactions [42,43]. The 3-D structure and interactions
of CDT with LPS micelle may provide mechanistic insights toward
outer membrane permeabilization and endotoxin neutralization. The
Fig. 10. Perturbations of LPS micelles by CDT. (panel A) Disaggregation of FITC labeled
LPS by CDT using FITC ﬂuorescence. The ﬂuorescence intensity of FITC increases as a
function of increasing concentrations of CDT peptide. Fluorescence studies were per-
formed in 10 mM sodium phosphate buffer, pH 6.0 at 298 K. (panels B and C) Particle
size measurements of LPS in free (panel B) and in the presence of CDT (panel C)
from quasi elastic light scattering measurements. The average size of aggregates of
LPS (panel B) is observed to decrease upon addition of CDT in a 1:2 molar ratio
(panel C). Experiments were carried out in 10 mM sodium phosphate buffer, pH 6.0
at 298 K.
Fig. 11. Mode of interaction of CDT with LPS: a molecular model of CDT–LPS complex
showing close proximity of the negatively charged phosphate groups of glucosamine
1 and glucosamine 2 of the lipid A moiety of LPS with the sidechains of cationic resi-
dues R7, R12 and R13. The sidechains of residues R11 and W4, with probable cation–π
interactions, are rather deeply inserted, along with other aromatic and non-polar resi-
dues, to the hydrophobic acyl region of LPS. The image was produced using INSIGHTII.
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charged surface patch of residues R4, R7, R12 and R13 (Fig. 8D). As
expected, these basic residues would be interacting, salt bridges and/
or hydrogen bonds, with the anionic phosphate groups of LPS, as
revealed from zeta potential experiments (Fig. 2). STD-NMR studies
established a close proximity of the cationic sidechains of Arg residues
with LPS micelle (Fig. 9). To obtain a molecular model of LPS–CDT in-
teractions, the β-hairpin structure of CDT was iteratively docked with
the lipid Amoiety of LPS (Fig. 11). In particular, the guanidiniumgroup
of residue R7 of CDT is in close proximity to the phosphate group lo-
cated at the O4′ position of glucosamine II, whereas the di-phosphate
at the O1 position of glucosamine I can potentially form a number of
salt-bridge interactions with residues R12 and R13 (Fig. 11). Theguanidinium sidechain of R4 is also likely to be involved in a long-
range ionic interaction with the di-phosphate groups of glucosamine
I (Fig. 11). Notably, the guanidinium groups of R7 and R12/R13 in
the β-hairpin structure of CDT maintain an inter-sidechain distance
of ~15 Å closely matching the inter-phosphate distance, of 13 Å, be-
tween the O1 andO4 phosphate groups of lipid A (Fig. 8E). The amphi-
pathic structure of CDT demarcates a hydrophobic surface consisted of
residues W2, F3, Y6, I9 and Y10 (Fig. 8). The basic residue R11 also re-
sides at the hydrophobic face as a result of close packing with the in-
dole ring of W2 (Fig. 8). STD-NMR reveals involvement of these
aromatic and aliphatic residues including R11, through the sidechain
moieties, in LPS binding (Fig. 9). The model of LPS–CDT complex
shows that the hydrophobic surface of the structure of CDT can insert
along the acyl chains of the LPS lipids (Fig. 11). As seen, the blue shift
in the emission maximum of Trp and a limited quenching by acrylam-
ide indicated a plausible inclusion of the ﬂuorophore into the hydro-
phobic core of LPS micelle (Fig. 3). The positively charged sidechain
of R11 can be favorably placed at the hydrophobic milieu of LPS
(Fig. 11) as a consequence of the interactions, cation–π type, with an
indole ring of W2 [70]. Such cationic–π interactions, speciﬁcally be-
tween Arg and Trp, have been proposed to shield the charge and
may allow a deeper penetration of the AMPs inside the hydrophobic
environment of lipid bilayer structure [71,72]. Insertion of CDT within
the LPS micelle leads to signiﬁcant perturbation of the LPS packing or-
ganization. The enhanced ﬂuorescence of FITC-conjugated LPS and
generation of smaller micelles of LPS observed upon addition of CDT
peptide suggested diminution of interactions among LPS lipids
(Fig. 10). Thus, these interactions between CDT and LPS may lead to
a plausible disruption or ﬂuidization of LPS structures facilitating
1623R. Saravanan et al. / Biochimica et Biophysica Acta 1818 (2012) 1613–1624traversal of the peptide through the LPS-outer membrane. The com-
pact β-hairpin structure of CDT will certainly aid in the process of per-
meation through the outer membrane. In conclusion, we demonstrate
that CDT, the Cys deleted analog TP-I, assumes a β-hairpin like unique
three-dimensional structure, despite the absence of disulﬁde bonds, in
complex with LPS micelles. It is noteworthy that this is the ﬁrst struc-
ture of a host-defense AMP in the LPS micelle that belongs to the β-
hairpin family. Thus far largely helical structures of AMPs had been
reported in LPS lipids [28–30,47,73]. In addition, current study iden-
tiﬁes important structural features of CDT for LPS recognition and pro-
vides a plausible mechanism of the outer membrane disruption. We
believe that structure of CDT in LPS and other ﬁndings in this study
may be utilized for the development of new antimicrobials, possibly
with the incorporation of ﬂuorinated amino acid analogs [74], with
enhanced binding afﬁnity for endotoxin.
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